Edwards Lifesciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	49,219	49,505	43,574	45,834	45,385	80,852
Market Cap Growth	10.26%	13.61%	-4.93%	0.99%	-43.87%	41.96%
Enterprise Value	46,506	45,959	40,339	44,933	44,836	80,050
Last Close Price	85.48	85.25	74.03	76.25	74.61	129.55
PE Ratio	46.58	46.58	10.62	33.15	30.58	54.43
Forward PE	28.03	30.93	31.19	28.41	30.35	52.98
PEG Ratio	2.33	3.24	3.69	2.77	2.95	3.38
PS Ratio	7.85	8.16	8.01	9.15	10.17	15.45
PB Ratio	4.80	4.79	4.36	6.89	7.82	13.85
P/TBV Ratio	4.83	4.83	4.44	6.99	8.02	14.01
P/FCF Ratio	45.43	37.08	150.31	71.30	46.62	57.49
P/OCF Ratio	36.43	31.03	80.35	51.17	37.26	46.68
EV/Sales Ratio	7.38	7.57	7.42	8.97	10.04	15.30
EV/EBITDA Ratio	24.43	32.35	26.30	30.91	27.37	43.86
EV/EBIT Ratio	26.69	36.35	29.26	34.33	29.92	47.36
EV/FCF Ratio	42.69	34.43	139.15	69.90	46.05	56.92
Debt / Equity Ratio	0.07	0.07	0.07	0.10	0.11	0.11
Debt / EBITDA Ratio	0.47	0.50	0.46	0.47	0.42	0.38
Debt / FCF Ratio	0.65	0.53	2.42	1.07	0.71	0.49
Net Debt / Equity Ratio	-0.29	-0.34	-0.33	-0.14	-0.09	-0.13
Net Debt / EBITDA Ratio	-1.97	-2.48	-2.14	-0.65	-0.32	-0.42
Net Debt / FCF Ratio	-2.72	-2.64	-11.30	-1.47	-0.54	-0.55
Asset Turnover	0.47	0.45	0.49	0.57	0.53	0.66
Inventory Turnover	1.24	1.21	1.12	1.10	0.90	1.63
Quick Ratio	3.30	2.83	3.12	2.06	1.87	2.07
Current Ratio	4.42	3.72	4.18	3.38	3.03	3.08
Return on Equity (ROE)	10.39%	10.39%	16.70%	19.48%	22.74%	28.88%
Return on Assets (ROA)	8.24%	7.84%	11.09%	13.18%	15.55%	18.97%
Return on Invested Capital (ROIC)	13.97%	13.73%	17.40%	18.23%	21.56%	27.15%
Return on Capital Employed (ROCE)	11.32%	10.79%	13.98%	16.96%	20.33%	24.47%
Earnings Yield	2.21%	2.15%	9.42%	3.02%	3.27%	1.84%
FCF Yield	2.20%	2.70%	0.67%	1.40%	2.15%	1.74%
Buyback Yield / Dilution	1.88%	2.25%	1.66%	2.37%	1.11%	0.11%
Total Shareholder Return	1.88%	2.25%	1.66%	2.37%	1.11%	0.11%

SEC Filings: 10-K · 10-Q